Cy Credille is a highly skilled synthetic organic chemist with extensive experience in both process and discovery chemistry. Currently serving as a Senior Principal Scientist and group leader in the process chemistry team at Cambrex Longmont, Cy plays a pivotal role in advancing the development...
Cy Credille is a highly skilled synthetic organic chemist with extensive experience in both process and discovery chemistry. Currently serving as a Senior Principal Scientist and group leader in the process chemistry team at Cambrex Longmont, Cy plays a pivotal role in advancing the development of active pharmaceutical ingredients (APIs). Leading a talented team of over seven synthetic chemists, he is dedicated to creating scalable and ICH-compliant synthetic routes that meet the rigorous demands of the pharmaceutical industry.
Cy's expertise encompasses a wide range of key projects, particularly in process discovery research and late-stage process development. His work spans from pre-IND to NDA-enabling research, where he focuses on optimizing synthetic pathways and ensuring compliance with regulatory standards. His hands-on experience in kilo-lab synthesis is crucial for producing GLP toxicology batches and manufacturing demonstration batches, which are essential for advancing drug candidates through the development pipeline.
In addition to his technical skills in organic synthesis and medicinal chemistry, Cy employs advanced methodologies such as Design of Experiments (DoE) and impurity fate and purge analysis to enhance process efficiency and robustness. His commitment to innovation and excellence in process R&D not only drives project success but also contributes to the overall mission of Cambrex in delivering high-quality pharmaceutical solutions. With a strong foundation in chemical engineering and a passion for research, Cy continues to make significant contributions to the field, ensuring that the next generation of therapeutics is developed with precision and care.
